Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Burkitt Lymphoma 1

Interventions

zilucoplan 1 tocilizumab 1 rozanolixizumab 1 fludarabine 1 blinatumomab 1 Tablets 1 Cyclophosphamide 1 Albuterol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Myasthenia Gravis × tocilizumab × Clear all

NCT05716035 2024-01-22

tMG-E

Tang-Du Hospital

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡